More than 50% of pregnant women in the EU are carriers of gene variants that inhibit folic acid (vitamin B9) and cobalamin (vitamin B12) metabolism, leading to deficiencies that provoke maternal and foetal health complications.
Scientists are struggling to reach a consensus on guidance of cocoa consumption for patients with type-2 diabetes mellitus (T2DM) as conflicting evidence makes it difficult to determine precise dose-to-response outcomes.
Trends in Japan’s Foods with Function Claims (FFC), the demand for vegan-friendly omega-3 based on insights from Thai Union, and an upcoming business summit in Singapore for the health and nutrition industry are featured in this round-up.
The American Herbal Products Association is urging members and stakeholders to contact lawmakers to oppose the mandatory product listing language that has been attached to a ‘must pass’ fee reauthorization bill.
A Mediterranean diet supplemented with almonds (MDSA) can help mitigate obesity-related white adipose tissue (WAT) dysfunction and reduce risk factors for diabetes and cardiovascular disease, according to new research.
A new study that sampled dozens of commercially available CBD products found detectable THC levels in 64% of them. Some levels were high enough to approach therapeutic thresholds or to potentially trigger drug test failures.
Proposals to overhaul the UK Cannabidiol (CBD) approval system has led to tension among some members of the Secretariat Advisory Board (SAB) of the All-Party Parliamentary Group (APPG) that liaises with government to inform industry policies.
Short-term consumption of blueberries can improve health outcomes in adults at high-risk of cardiovascular disease (CVD) but results on healthy individuals are ambiguous and require further investigation to establish long-term outcomes.
Palmitoylethanolamide (PEA) has shown to inhibit the COVID-19 virus in both in-silico and in-vitro settings, and positive findings from a clinical trial are expected to be published in Q3, says functional ingredient firm Gencor.
New Zealand is pumping in cash to boost its cherry-growing industry by funding research to assess the nutritional value of the stone fruit that has been purported to reduce inflammation, regulate blood pressure and improve sleep among many.
With more than one billion women expected to have entered menopause worldwide by 2025, Bonafide is highlighting the need to increase education on preparing, managing, and addressing solutions for menopause symptoms.
Between worker shortages, plant shutdowns, trucking issues, backups at the ports, supply chains are pinched and prices are growing. Every industry is feeling the inflation burn – and the health and wellness sector is no exception. According to SPINS,...
Health and wellness company Onnit has added a new study to its growing portfolio of clinical trials to validate the benefits of the “total human optimization” brand’s range of multi-ingredient supplements.
The dietary supplements industry has reacted to a recent report from the U.S. Preventive Services Task Force that dismissed the potential benefits of multivitamins for the prevention of cardiovascular disease and cancer.
Last week’s meeting of the U.S. Food and Drug Administration’s Science Board did little to assuage a frustrated CBD industry that continues to call for regulation of the cannabinoid as a dietary supplement.
With consumers increasingly demanding scientifically-validated nutra products and ingredients, one of the key scientists in Australia’s national research agency has revealed the three factors that are crucial for a high-quality trial.
Vitamin D levels marginally increased in people who received low dose vitamin D3 alone or combined with calcium, compared to a decline seen in those who received calcium supplement alone or a placebo, according to a new RCT from the UAE.
Supplement companies must enact policies to fight and prevent modern slavery across their supply chains, ensure clear accountability and governance structures, and coordinate efforts to increase education on modern slavery among staff and suppliers.